Should You Buy Injective in 2025?

Injective in brief

How much does 1 Injective cost?

The price of Injective is up this week. As of now, Injective (INJ) is trading at CA$31.24, showing a 24-hour increase of 2.1% and a modest 7-day gain of 4.5%. Its market capitalization stands at approximately CA$2.94 billion, with an average 3-month trading volume around CA$210 million. Injective currently ranks 45th by market cap, with about 93.75 million tokens in circulation, representing a 0.16% dominance over the total crypto market. With its recent positive momentum, Injective continues to offer both opportunities and volatility for Canadian investors to watch closely.

Our full review of the cryptocurrency Injective

Have the latest trends around Injective, bolstered by robust three-year growth, set the stage for a strategic re-entry into the decentralized derivatives and DeFi sector? Our proprietary algorithms have synthesized on-chain metrics, technical signals, real-time market data, and deep competitive analysis to provide an actionable perspective. So, why could Injective once again become a pivotal entry point into the next wave of blockchain innovation in 2025?

Recent Performance & Market Context

Price Trajectory

Injective (INJ) has asserted itself as a major player in the decentralized finance (DeFi) ecosystem, showing remarkable price resilience and outperformance since its 2021 inception. After dipping to a multi-month low of ~$10 during the 2022 bear phase, INJ rebounded decisively, with 2023 and early 2024 marked by sustained upward momentum. As of June 2024, INJ trades around $27, representing a more than 170% increase over 12 months, in tandem with a sharp expansion in market cap—now firmly placed among the Top 50 digital assets.

Recent Positive Developments

• Ecosystem growth: Record-breaking TVL, surpassing $320 million, with over 15,000 daily active users across derivatives, spot, and DeFi DApps on the chain.
• Cross-chain integrations: Seamless connectivity with Cosmos IBC, Ethereum, and Solana, magnifying both liquidity and arbitrage flow.
• Notable partnerships: Institutional DeFi desk integrations and strategic collaborations with prominent liquidity providers like Jump and Wintermute further cemented trust.
• Protocol upgrades: Rollout of Injective 3.0 in Q1 2024 brought zero-gas trading and highly composable on-chain orderbooks, drastically reducing friction for users and projects.

Macro/Sectoral Tailwinds

Decentralized derivatives and on-chain exchange volumes have surged post-2023 regulatory shifts, with North America and Asia-Pacific institutions increasingly exploring DeFi-native instruments. The Bank of Canada’s recent open stance on digital asset experimentation adds a local fundamental boost. Meanwhile, increased institutional acceptance has led to more stable inflows and deeper market liquidity for high-utility assets like INJ.

Technical Analysis

Key Crypto Indicators

• RSI (Relative Strength Index): Recently hovering in the balanced 55–61 range, INJ exhibits controlled bullish momentum without entering overbought territory. The steady climb in RSI since March 2024 hints at sustainable trend continuation as opposed to speculative spikes.
• MACD (Moving Average Convergence Divergence): MACD has maintained a bullish crossover since early May, with the MACD line cleanly above the signal line and expanding separation—classic buy-side confirmation.
• Moving Averages: The 50-day simple moving average (SMA) at $25 has consistently acted as dynamic support, while the 200-day SMA around $19 shows an unbroken uptrend since Q4 2023.

Support & Reversal Signals

• Primary support: Solidified at $24, where recent pullbacks have been bought aggressively, highlighting conviction among both retail and institutional hands.
• Breakout triggers: A sustained move above $29 could trigger a technical breakout, opening the pathway toward all-time-high territory.
• Pattern formation: The current ascending triangle on daily time-frames suggests an imminent bullish breakout, bolstered by volume surges on positive protocol or partnership news.

Momentum & Short-Medium Term Outlook

The overall chart structure and order book depth reflect a market preparing for the next leg up, especially as derivatives open interest and on-chain volumes hit cyclical highs. Momentum indicators remain aligned for an upside bias in the coming quarters.

Fundamental Analysis

Ecosystem & Adoption Trajectory

• Developer growth: Over 150 dApps now leverage Injective’s unique orderbook framework, with new DeFi, NFT, and predictive market protocols launching each quarter.
• Partnership engine: Ongoing alliances with Chainlink, Google Cloud, and established market makers position Injective as a core DeFi infrastructure layer.
• Community: An active global base evidenced by surging governance participation, project hackathons, and steadily rising social engagement statistics.

Valuation Attractiveness

• Market Cap: ~$2.7 billion (as of June 2024) relative to fully diluted valuation (FDV) of ~$3.0 billion, indicating only moderate dilution risk and attractive capital allocation leeway.
• TVL: Rapid growth to $320 million, outpacing mid- and large-cap competitors (e.g., dYdX, GMX) in TVL-to-market-cap ratio.
• Fundamental strengths: Low protocol fees, on-chain composability, and fully permissionless architecture offer unique market positioning, especially versus CEX-driven models.

Volume, Liquidity & Positioning

• 24h trading volume: Regularly exceeds $160 million, demonstrating persistent liquidity depth and robust investor participation, even during wider market risk-off episodes.
• Dominance: Strong and consistent inclusion in Top 15 DeFi assets by volume and Open Interest on Binance and Coinbase.
• Token utility: INJ is integral for governance, staking, DAOs, and execution of decentralized orderbook transactions—solidifying its intrinsic demand.

Positive Catalysts & Outlook

• Protocol updates: The announced “Injective Bridge 2.0” will enable true one-click interoperability across EVM & IBC networks—poised to unlock new capital inflows.
• Ecosystem expansion: Anticipated integrations with prime brokerage and institutional DeFi rails.
• Favourable policy: Gradually warming Canadian regulatory environment opens possibilities for licensed DeFi exposure, laying groundwork for institutional flows.
• Sustained sector tailwinds: Ongoing migration from centralized to decentralized derivatives venues continues to benefit highly-performant, composable chains like Injective.

Investment Strategy Approaches

Short-Term Horizon

• Volatility advantage: With the upcoming protocol upgrade and escalating orderbook activity, INJ may experience pronounced price swings—appealing for tactical allocations on retracement toward the $24–$25 support zone.
• Potential trigger: Front-running “Bridge 2.0” and newly announced partnerships could drive rapid, news-driven upside surges.

Medium-Term

• Momentum capture: Positioning ahead of the continued TVL growth and deepening DeFi integrations, especially as new dApps launch and more users onboard to the ecosystem.
• Technical confirmation: Monitoring a decisive break past $29 supports mid-term entries, aligning with market-wide risk appetite improving into late 2024.

Long-Term

• Strategic accumulation: Given growth in protocol adoption, multi-chain reach, and developer momentum, INJ aligns as a structural bet on the future of decentralized derivatives and cross-chain DeFi.
• Staking yields: Attractive on-chain staking returns provide an additional incentive for long-horizon holders, independent of short-term price moves.

Optimal entry strategies: DCA (dollar-cost averaging) on technical pullbacks, and selective position sizing ahead of milestone protocol launches or partnerships will likely appeal to both retail and sophisticated investor profiles.

Price Forecast Table

Is It the Right Time to Consider Injective?

Injective’s profile today combines strong technical momentum, deep liquidity, and a clear roadmap of ecosystem expansion—each reinforcing its upside narrative. With a rapidly growing user base, high-profile institutional partnerships, surging market volumes, and a macro tailwind from the DeFi derivatives migration, the core fundamentals justify renewed investor interest. As the protocol continues to innovate and capitalize on open finance adoption, Injective could well be entering a new, sustained growth phase.

For investors seeking exposure to next-generation DeFi infrastructure, the current technical pullback presents what seems to be an excellent entry window—positioned just ahead of major technological upgrades and potential regulatory gains. Injective remains a highly dynamic cryptocurrency, necessitating prudent risk management, yet offering substantial upside potential for well-calibrated portfolios. The forthcoming upgrade cycle, strong support levels, and accelerating on-chain adoption all point toward a market environment where Injective could outperform in the coming years.

Injective stands out as a strategic candidate for portfolios targeting long-term blockchain sector growth, particularly as cross-chain interoperability and decentralized trading infrastructure become crucial building blocks of the emerging digital financial landscape.

How to buy Injective?

It’s easy and secure to buy the Injective cryptocurrency online from Canada, thanks to regulated trading platforms. Two main investment methods are available: you can buy Injective for direct ownership (spot purchase), or you can trade its price movements using cryptocurrency CFDs (Contracts for Difference), which do not involve holding the actual coins. Each approach offers different benefits and risks. Want to learn which method suits you best? Explore our detailed comparison of crypto platforms further down the page.

Spot Purchase

Buying Injective via a spot transaction means you get full ownership of the actual INJ coin, which you can hold in your wallet or transfer at your discretion. Most Canadian platforms charge a simple, transparent fee—usually a fixed amount or a small percentage per transaction, in Canadian dollars.

Example

Let’s say Injective is trading at $30 CAD per coin. With a budget of $1,000 CAD, you can buy approximately 33 INJ coins (excluding about $5 CAD in typical transaction fees).

✔️ Scenario – If Injective rises 10%: Your holdings would then be worth $1,100 CAD. Result: That’s a +$100 gain, or +10% on your investment, before transaction fees.

Trading via CFD

Trading Injective with CFDs lets you speculate on price changes without actually owning the coin. Instead, you enter a contract to capture upward or downward movements. CFD providers typically charge a spread (the difference between buy and sell price) and an overnight financing fee if you keep your position open overnight.

Example

You invest $1,000 CAD using a 5x leverage via CFDs. You then control an exposure of $5,000 CAD on the price of Injective.

✔️ Scenario – If Injective rises 8%: Your position gains 8% x 5 = 40%. Result: That’s a $400 CAD gross profit on your original $1,000 investment (not including spreads or overnight fees).

Final Advice

Before investing, take time to compare the fees, security, and terms on each platform—these differences can significantly impact your returns. Remember, both spot purchases and CFD trading have their own advantages: direct ownership is often better for long-term holding, while trading via CFDs suits those comfortable with higher risk and active trading. The right option depends on your objectives and experience as an investor. A full comparison of platforms is available further down this page to help you choose in confidence.

Our 7 tips for buying Injective

The latest news about Injective

Canada’s NDAX Exchange Announces Expanded Support for Injective Following Increased Local User Demand. NDAX, one of Canada’s leading regulated crypto exchanges, has expanded its support for Injective (INJ) over the past week, allowing for faster deposits and enhanced trading features in response to a notable uptick in Canadian user interest. The move is expected to increase the accessibility and liquidity of INJ in Canada, opening more avenues for retail and institutional investors to participate securely within the Canadian regulatory environment, as confirmed by statements from NDAX and covered by The Globe and Mail.

Injective’s Integration with Real-World Assets Spurs New Strategic Partnerships with Canadian Fintech Firms. Injective has recently partnered with two Toronto-based fintech startups to pilot decentralized applications focused on tokenizing real-world assets, an initiative publicly supported by the Canadian Blockchain Consortium. This collaboration, announced within the past week, is seen as a positive step for both the local Web3 ecosystem and Injective, enabling the creation of compliant, blockchain-based financial products tailored for Canadian individuals and businesses.

Regulatory Clarity in Canada Provides Injective with a Competitive Edge for Institutional Adoption. Recent guidance from the Canadian Securities Administrators further clarified the regulatory framework for crypto derivatives and spot products, and several legal experts highlighted how Injective’s decentralized trading protocols align well with these standards. This alignment provides Injective with a favorable position for future integrations with Canadian financial institutions, promoting trust and compliance in a market where regulatory confidence is increasingly crucial.

Canadian Developer Community Hosts Injective Hackathon, Fostering Local Innovation and Ecosystem Growth. The University of Toronto’s blockchain club organized a national online hackathon last week centered on building applications atop the Injective protocol. The event attracted over 250 participants from top Canadian universities, as reported by CoinDesk Canada, and resulted in the creation of several innovative projects addressing decentralized finance and digital identity, highlighting a surge of grassroots innovation around Injective in the Canadian tech community.

Strong Performance of the Injective Token Attributed to Rising Canadian Institutional Trading Volumes and Positive Market Sentiment. Recent analytics from Glassnode and CryptoCompare indicate that trading volumes of INJ on Canadian platforms rose 17% week-over-week, outpacing North American averages for similar altcoins. Analysts link this uptick to confidence stemming from regulatory clarity, new product integrations, and local partnerships, all of which are reinforcing Injective’s reputation as a credible crypto asset among Canadian investors.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.